Global Pharmaceuticals & Biotech Big Green Snowflakes

Protalix BioTherapeutics

Market Cap: US$126.8m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

ICON

Market Cap: US$13.7b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

Veracyte

Market Cap: US$2.6b

Operates as a diagnostics company in the United States and internationally.

Day One Biopharmaceuticals

Market Cap: US$759.0m

A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.

Cardiff Oncology

Market Cap: US$141.7m

A clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers.

Lipocine

Market Cap: US$15.7m

A clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders.

Pharming Group

Market Cap: €880.4m

A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.

Bangkok Lab And Cosmetic

Market Cap: ฿2.6b

Manufactures and distributes pharmaceuticals and medicinal chemical products for humans and animals in Thailand, Laos, Cambodia, Hongkong, Myanmar, and internationally.

Synmosa Biopharma

Market Cap: NT$17.4b

A specialty pharmaceutical company, researches, develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand in Taiwan.

Zhejiang Huahai Pharmaceutical

Market Cap: CN¥40.1b

Operates as a pharmaceutical company in China and internationally.

GemPharmatech

Market Cap: CN¥7.2b

A contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide.

Hikal

Market Cap: ₹32.3b

Manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, biotechnology, life sciences, animal health, crop protection, and specialty chemicals indusries.

Novogene

Market Cap: CN¥6.1b

Provides genomic services and solutions in Mainland China, Hong Kong, Macau, Taiwan, and internationally.

Mercury Laboratories

Market Cap: ₹1.0b

Engages in manufacturing, selling, exporting, and dealing in various pharmaceutical drugs and medicines for mother and child healthcare in India and internationally.

Beijing Foyou PharmaLTD

Market Cap: CN¥11.5b

Engages in the research and development, production, and sale of pharmaceutical preparations and medical equipment.

Aurobindo Pharma

Market Cap: ₹606.4b

A biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables.

Lee's Pharmaceutical Holdings

Market Cap: HK$1.3b

An investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally.

Chongqing Zhifei Biological Products

Market Cap: CN¥52.5b

Chongqing Zhifei Biological Products Co., Ltd.

Hanall Biopharma

Market Cap: ₩1.6t

A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.

Shanghai Haoyuan Chemexpress

Market Cap: CN¥14.8b

Researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs.

AFT Pharmaceuticals

Market Cap: NZ$283.1m

Develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.

JFL Life Sciences

Market Cap: ₹471.8m

Engages in the manufacture and sale of pharmaceutical products in India and internationally.

Medicamen Organics

Market Cap: ₹432.9m

Engages in the developing, manufacturing, and distribution of a range of pharmaceutical dosage in India and internationally.

OSE Immunotherapeutics

Market Cap: €134.5m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

SCHOTT Pharma KGaA

Market Cap: €3.3b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.

Sagimet Biosciences

Market Cap: US$235.8m

A clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic pathways in the United States.

NUTEX Investments

Market Cap: Ft2.6b

Provides health preserving, health improving, dietary supplement, and cosmetic products in Hungary and internationally.

Cingulate

Market Cap: US$20.5m

A biopharmaceutical company, develops pharmaceutical products using delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States.

RenovoRx

Market Cap: US$43.6m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

Sprint Bioscience

Market Cap: SEK 64.4m

A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.

INmune Bio

Market Cap: US$51.0m

A clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States.

Ascelia Pharma

Market Cap: SEK 501.8m

A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.

Physiomics

Market Cap: UK£1.3m

Provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland.

Darwin

Market Cap: €79.2m

Operates as a biotechnology company.

Blau Farmacêutica

Market Cap: R$2.5b

A pharmaceutical company provides high-complpexity drugs in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.

Halozyme Therapeutics

Market Cap: US$8.6b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.